Scalar Relativistic All-Electron and Pseudopotential Ab Initio Study of a Minimal Nitrogenase [Fe(SH) 4 H] − Model Employing Coupled-Cluster and Auxiliary-Field Quantum Monte Carlo Many-Body Methods
The Journal of Physical Chemistry A · 22.02.2024 · 128 (7) · 1358-1374
DOI: 10.1021/acs.jpca.3c05808 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry A, online erschienen am 07.02.2024. Verfasst von Victor P Vysotskiy und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Computational Chemistry, Lund University, Chemical Centre, SE-221 00 Lund, Sweden. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Vetenskapsrådet.
Abstract (Originalsprache)
Nitrogenase is the only enzyme that can cleave the triple bond in N2, making nitrogen available to organisms. The detailed mechanism of this enzyme is currently not known, and computational studies are complicated by the fact that different density functional theory (DFT) methods give very different energetic results for calculations involving nitrogenase models. Recently, we designed a [Fe(SH)4H]- model with the fifth proton binding either to Fe or S to mimic different possible protonation states of the nitrogenase active site. We showed that the energy difference between these two isomers (ΔE) is hard to estimate with quantum-mechanical methods. Based on nonrelativistic single-reference coupled-cluster (CC) calculations, we estimated that the ΔE is 101 kJ/mol. In this study, we demonstrate that scalar relativistic effects play an important role and significantly affect ΔE. Our best revised single-reference CC estimates for ΔE are 85-91 kJ/mol, including energy corrections to account for contributions beyond triples, core-valence correlation, and basis-set incompleteness error. Among coupled-cluster approaches with approximate triples, the canonical CCSD(T) exhibits the largest error for this problem. Complementary to CC, we also used phaseless auxiliary-field quantum Monte Carlo calculations (ph-AFQMC). We show that with a Hartree-Fock (HF) trial wave function, ph-AFQMC reproduces the CC results within 5 ± 1 kJ/mol. With multi-Slater-determinant (MSD) trials, the results are 82-84 ± 2 kJ/mol, indicating that multireference effects may be rather modest. Among the DFT methods tested, τ-HCTH, r2SCAN with 10-13% HF exchange with and without dispersion, and O3LYP/O3LYP-D4, and B3LYP*/B3LYP*-D4 generally perform the best. The r2SCAN12 (with 12% HF exchange) functional mimics both the best reference MSD ph-AFQMC and CC ΔE results within 2 kJ/mol.
Autor:innen und Institutionen
- Department of Computational Chemistry, Lund University, Chemical Centre, SE-221 00 Lund, Sweden.
- MESA+ Institute for Nanotechnology, University of Twente, P.O. Box 217, Enschede 7500 AE, Netherlands.
ORCID-Profile: Victor P Vysotskiy, Claudia Filippi, Ulf Ryde
Förderung
- Vetenskapsrådet
Zitieren
APA
Vysotskiy, V. P., Filippi, C., & Ryde, U. (2024). Scalar Relativistic All-Electron and Pseudopotential Ab Initio Study of a Minimal Nitrogenase [Fe(SH) 4 H] − Model Employing Coupled-Cluster and Auxiliary-Field Quantum Monte Carlo Many-Body Methods. The Journal of Physical Chemistry A, 128(7), 1358-1374. https://doi.org/10.1021/acs.jpca.3c05808
Vancouver
Vysotskiy VP, Filippi C, Ryde U. Scalar Relativistic All-Electron and Pseudopotential Ab Initio Study of a Minimal Nitrogenase [Fe(SH) 4 H] − Model Employing Coupled-Cluster and Auxiliary-Field Quantum Monte Carlo Many-Body Methods. The Journal of Physical Chemistry A. 2024;128(7):1358-1374. doi:10.1021/acs.jpca.3c05808
BibTeX
@article{Vysotskiy2024,
author = {Vysotskiy, Victor P and Filippi, Claudia and Ryde, Ulf},
title = {Scalar Relativistic All-Electron and Pseudopotential Ab Initio Study of a Minimal Nitrogenase [Fe(SH) 4 H] − Model Employing Coupled-Cluster and Auxiliary-Field Quantum Monte Carlo Many-Body Methods},
journal = {The Journal of Physical Chemistry A},
year = {2024},
volume = {128},
number = {7},
pages = {1358--1374},
doi = {10.1021/acs.jpca.3c05808}
}
EUVIMED